Single dose oral bioequivalence study of Cladribine 10 mg Tablets and Mavenclad® 10 mg tablets (Cladribine) in healthy adult human subjects under fed conditions
CPO25001
Phase 1 other active
Quick answer
Single dose oral bioequivalence study of Cladribine 10 mg Tablets and Mavenclad® 10 mg tablets (Cladribine) in healthy adult human subjects under fed conditions for No therapeutic indication in the current trial with healthy volunteers. is a Phase 1 program (other) at Lacuna Pharma Pty Ltd with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Lacuna Pharma Pty Ltd
- Indication
- No therapeutic indication in the current trial with healthy volunteers.
- Phase
- Phase 1
- Modality
- other
- Status
- active